Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2012-002356-16Phase 4Completed
Phase 4, randomised trial of Marcain in postoperative pain (2 arms), sponsored by Stavanger University Hospital. Primary endpoint: Movement-evoked pain (MEP). Started Jul 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2012-002356-16.